Vaccination with Allogeneic Dendritic Cells Fused to Carcinoma Cells Induces Antitumor Immunity in MUC1 Transgenic Mice

This publication has 37 references indexed in Scilit:

• Dendritic Cells Retrovirally Transduced with a Model Antigen Gene Are Therapeutically Effective against Established Pulmonary Metastases
  The Journal of Experimental Medicine, 1997
• Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells
  Gene Therapy, 1997
• Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity.
  The Journal of Experimental Medicine, 1996
• Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
  Nature Medicine, 1995
• Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.
  The Journal of Experimental Medicine, 1995
• Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo
  European Journal of Immunology, 1994
• Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo.
  The Journal of Experimental Medicine, 1993
• Signals arising from antigen-presenting cells
  Current Opinion in Immunology, 1991
• Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ.
  The Journal of Experimental Medicine, 1990
• Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro.
  The Journal of Experimental Medicine, 1989